These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 32575921)

  • 1. OMV Vaccines and the Role of TLR Agonists in Immune Response.
    Mancini F; Rossi O; Necchi F; Micoli F
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GMMA-Based Vaccines: The Known and The Unknown.
    Mancini F; Micoli F; Necchi F; Pizza M; Berlanda Scorza F; Rossi O
    Front Immunol; 2021; 12():715393. PubMed ID: 34413858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in outer membrane vesicles of gram-negative bacteria as sub-unit vaccines - A review].
    Yi J; Liu Q; Kong Q
    Wei Sheng Wu Xue Bao; 2016 Jun; 56(6):911-21. PubMed ID: 29727152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
    Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.
    Giordano NP; Cian MB; Dalebroux ZD
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32253250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
    Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles.
    Rosenthal JA; Huang CJ; Doody AM; Leung T; Mineta K; Feng DD; Wayne EC; Nishimura N; Leifer C; DeLisa MP; Mendez S; Putnam D
    PLoS One; 2014; 9(11):e112802. PubMed ID: 25426709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC).
    Hu R; Li J; Zhao Y; Lin H; Liang L; Wang M; Liu H; Min Y; Gao Y; Yang M
    Microb Cell Fact; 2020 Jun; 19(1):119. PubMed ID: 32493405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune modulation by bacterial outer membrane vesicles.
    Kaparakis-Liaskos M; Ferrero RL
    Nat Rev Immunol; 2015 Jun; 15(6):375-87. PubMed ID: 25976515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-Demand Vaccine Production via Dock-and-Display of Biotinylated Antigens on Bacterial Extracellular Vesicles.
    Weyant KB; Oloyede A; DeLisa MP
    Methods Mol Biol; 2024; 2843():195-216. PubMed ID: 39141302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outer membrane vesicles of Gallibacterium anatis induce protective immunity in egg-laying hens.
    Pors SE; Pedersen IJ; Skjerning RB; Thøfner ICN; Persson G; Bojesen AM
    Vet Microbiol; 2016 Nov; 195():123-127. PubMed ID: 27771057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gram-negative outer membrane vesicles in vaccine development.
    Collins BS
    Discov Med; 2011 Jul; 12(62):7-15. PubMed ID: 21794204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of Naturally Released Gonococcal Outer Membrane Vesicles as Vaccine Antigens.
    Francis IP; Lui X; Wetzler LM
    Methods Mol Biol; 2019; 1997():121-141. PubMed ID: 31119622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.
    Roier S; Blume T; Klug L; Wagner GE; Elhenawy W; Zangger K; Prassl R; Reidl J; Daum G; Feldman MF; Schild S
    Int J Med Microbiol; 2015 May; 305(3):298-309. PubMed ID: 25592265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of outer membrane vesicle-based immune responses by cathelicidins.
    Balhuizen MD; Versluis CM; van Grondelle MO; Veldhuizen EJA; Haagsman HP
    Vaccine; 2022 Apr; 40(16):2399-2408. PubMed ID: 35307226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
    Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
    Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial outer membrane vesicles in disease and preventive medicine.
    Unal CM; Schaar V; Riesbeck K
    Semin Immunopathol; 2011 Sep; 33(5):395-408. PubMed ID: 21153593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.